Within the past couple of decades, the healthcare sector has witnessed advancements and innovations. Research and development activities continue to bring to the fore new medications, therapies, and treatments. However, despite these advancements, unmet clinical requirements to treat degenerative conditions and orthopedic injuries continue to pose a major challenge for healthcare systems across the world. Advancements in bio implant engineering have paved the way for several biological alternatives that are aimed at retaining, modifying, and restoring the functionalities of different organs. Moreover, rapid progress in the material technology has enabled the deployment of an array of materials for implant applications.
Orthopedic biomaterials are increasingly being used for joint replacements, ortho biologics, spine implants, and bio-resorbable tissue fixation, among others. The demand for orthopedic biomaterials is expected to witness considerable growth during the forecast period (2019-2027), due to a range of factors. Some of the leading factors that are expected to steer the global orthopedic biomaterials market past US$ 21.3 Bn mark include exponential rise in aging population, shift toward nanophase materials from conventional materials, and growing adoption of 3D printed orthopedic implants. Stakeholders in the current orthopedic biomaterials market landscape are likely to focus on improving designs of nanophase materials to improve reliability and functionalities of implants.
Advancement in the 3D printing technology is expected to create a strong impact on the orthopedic biomaterials market during the forecast period, as stakeholders continue to explore its potential for tissue engineering. 3D printed implants, smart biomaterials, and porous structures are some of the trends one can expect within the orthopedic biomaterials market during the forecast period. These advancements in the orthopedic biomaterial market are anticipated to play a key role in the development of implants with improved functionalities. Although the commercialization of these orthopedic biomaterials was a major challenge for a considerable time period, at present, the adoption of orthopedic biomaterials is on the rise. Furthermore, due to drawbacks of conventional orthopedic biomaterials, including quality, implant life, and cost of the treatment, demand for advanced orthopedic biomaterials is projected to grow at a healthy pace during the assessment period, thus driving the orthopedic biomaterials market.
At present, the application of 3D printing within the tissue engineering and regenerative medicine field are bound by the choice of biomaterials, and research and development activities are expected to change the narrative in the coming years. Research and development activities are paving the way for new biomaterials that can be utilized in 3D printing techniques. The advent of 3D printing is expected to significantly boost the demand for orthopedic biomaterials, owing to the advantages associated with fabricating scaffolds. Some of the major benefits offered by 3D printing in the orthopedic biomaterial market include improved capability to develop complex geometries, co-culture of numerous cells, and most importantly integrate growth factors. At present, composites, polymers, and ceramics are some of the orthopedic biomaterials that are increasingly being used in biomaterial 3D printing.
In the past few years, there have been significant innovations in the regenerative medicines space due to the benefits of biomaterials. At present, biomaterial-based tissue engineering strategies are offering promising results due to which the demand for such ‘smart’ biomaterials is expected to witness substantial growth. Staggering developments as far as stem-cell-based techniques are concerned to have gradually opened the door for new and effective solutions to treat a range of diseases. In the current scenario, owing to the progress in nanotechnology, both natural as well as artificial biomaterials can be deployed to produce 3D scaffolds. Stakeholders in the current orthopedic biomaterials market are seeking solutions to improve the integration of implants made from orthopedic biomaterials. Research and development activities are focusing on finding new techniques wherein orthopedic biomaterials can be used to enhance healing and restoring different physiological functions of the bone. Modern-day bone tissue engineering techniques have largely benefitted from the use of biomaterials to create 3D biodegradable and porous bioactive scaffolds.
Analysts’ Viewpoint
The global orthopedic biomaterials market is expected to grow at a healthy CAGR of ~7% during the forecast period. The market growth can be largely attributed to the ascending demand for orthopedic implants, surge in the number of sports-related injuries, noteworthy advancements in technology, and growth in the number of research and development activities. Moreover, advancements in nanotechnology coupled with progress in the 3D printing space are expected to increase the demand for orthopedic biomaterials for tissue engineering. Despite facing a few hurdles while commercializing orthopedic biomaterials, since then the demand has moved in an upward trajectory. Research & development activities will play an imperative role in improving the functionalities of orthopedic biomaterials, which in turn will drive the orthopedic biomaterials market.
Orthopedic Biomaterials Market: Overview
Orthopedic Biomaterials Market: Drivers
Market Segmentation: Orthopedic Biomaterials Market
Regional Overview: Orthopedic Biomaterials Market
Major Players
The global orthopedic biomaterials market was worth US$ 11.3 Bn and is projected to reach a value of US$ 21.3 Bn by the end of 2027
Orthopedic biomaterials market is anticipated to grow at a CAGR of 7% during the forecast period
North America and Western Europe accounted for a major share of the global orthopedic biomaterials market
Orthopedic biomaterials market is driven by rise in percentage of population requiring orthopedic implants; increase in incidence rate of injuries related to accidents, sports, and adventure; surge in adoption of technologically advanced products; and rise in government initiatives to address unmet medical needs
Key players in the global orthopedic biomaterials market include Zimmer Biomet Holdings, Inc., Stryker, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, Medtronic, DJO Global, Inc., Arthrex, Inc., NuVasive, Inc., and Globus Medical, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Orthopedic Biomaterials Market
4. Market Overview
4.1. Introduction
4.1.1. Orthopedic Biomaterials Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Orthopedic Biomaterials Market Analysis and Forecasts, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Price Comparison Analysis
5.2. Key Potential Customers
5.3. Key Success Factors of Three Players
5.4. Key Industry Developments (Mergers & Acquisitions, Funding, Business Expansion, etc.)
5.5. Technological Advancements
5.6. Regulatory Scenario by Regional/Global
6. Global Orthopedic Biomaterials Market Analysis and Forecasts, by Material
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Material, 2017–2027
6.3.1. Glass-ceramic & Bioactive Glasses
6.3.2. Calcium Phosphate Cements
6.3.3. Polymers
6.3.4. Metals
6.3.5. Composites
6.4. Market Attractiveness, by Material
7. Global Orthopedic Biomaterials Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2027
7.3.1. Joint Replacements
7.3.2. Spine Implants
7.3.3. Orthobiologics
7.3.4. Viscosupplementation
7.3.5. Bio-resorbable Tissue Fixation
7.4. Market Attractiveness, by Application
8. Global Orthopedic Biomaterials Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Orthopedic Clinics
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Orthopedic Biomaterials Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Orthopedic Biomaterials Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Material, 2017–2027
10.2.1. Glass-ceramic & Bioactive Glasses
10.2.2. Calcium Phosphate Cements
10.2.3. Polymers
10.2.4. Metals
10.2.5. Composites
10.3. Market Value Forecast, by Application, 2017–2027
10.3.1. Joint Replacements
10.3.2. Spine Implants
10.3.3. Orthobiologics
10.3.4. Viscosupplementation
10.3.5. Bio-resorbable Tissue Fixation
10.4. Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Orthopedic Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Material
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Orthopedic Biomaterials Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Material, 2017–2027
11.2.1. Glass-ceramic & Bioactive Glasses
11.2.2. Calcium Phosphate Cements
11.2.3. Polymers
11.2.4. Metals
11.2.5. Composites
11.3. Market Value Forecast, by Application, 2017–2027
11.3.1. Joint Replacements
11.3.2. Spine Implants
11.3.3. Orthobiologics
11.3.4. Viscosupplementation
11.3.5. Bio-resorbable Tissue Fixation
11.4. Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Orthopedic Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Material
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Orthopedic Biomaterials Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Material, 2017–2027
12.2.1. Glass-ceramic & Bioactive Glasses
12.2.2. Calcium Phosphate Cements
12.2.3. Polymers
12.2.4. Metals
12.2.5. Composites
12.3. Market Value Forecast, by Application, 2017–2027
12.3.1. Joint Replacements
12.3.2. Spine Implants
12.3.3. Orthobiologics
12.3.4. Viscosupplementation
12.3.5. Bio-resorbable Tissue Fixation
12.4. Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Orthopedic Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Material
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Orthopedic Biomaterials Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Material, 2017–2027
13.2.1. Glass-ceramic & Bioactive Glasses
13.2.2. Calcium Phosphate Cements
13.2.3. Polymers
13.2.4. Metals
13.2.5. Composites
13.3. Market Value Forecast, by Application, 2017–2027
13.3.1. Joint Replacements
13.3.2. Spine Implants
13.3.3. Orthobiologics
13.3.4. Viscosupplementation
13.3.5. Bio-resorbable Tissue Fixation
13.4. Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Orthopedic Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Material
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Orthopedic Biomaterials Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Material, 2017–2027
14.2.1. Glass-ceramic & Bioactive Glasses
14.2.2. Calcium Phosphate Cements
14.2.3. Polymers
14.2.4. Metals
14.2.5. Composites
14.3. Market Value Forecast, by Application, 2017–2027
14.3.1. Joint Replacements
14.3.2. Spine Implants
14.3.3. Orthobiologics
14.3.4. Viscosupplementation
14.3.5. Bio-resorbable Tissue Fixation
14.4. Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Orthopedic Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Material
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Share Analysis, by Company (2018)
15.2. Company Profiles
15.2.1. Zimmer Biomet Holdings, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Growth Strategies
15.2.1.3. SWOT Analysis
15.2.2. Stryker
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Growth Strategies
15.2.2.3. SWOT Analysis
15.2.3. DePuy Synthes (Johnson & Johnson)
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Growth Strategies
15.2.3.3. SWOT Analysis
15.2.4. Smith & Nephew plc
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Growth Strategies
15.2.4.3. SWOT Analysis
15.2.5. Medtronic
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Growth Strategies
15.2.5.3. SWOT Analysis
15.2.6. DJO Global, Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Growth Strategies
15.2.6.3. SWOT Analysis
15.2.7. Arthrex, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Growth Strategies
15.2.7.3. SWOT Analysis
15.2.8. NuVasive, Inc.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Growth Strategies
15.2.8.3. SWOT Analysis
15.2.9. Globus Medical, Inc.
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Growth Strategies
15.2.9.3. SWOT Analysis
List of Tables
Table 01: Price Comparison Analysis: Spine Surgery in Region/Countries (US$ Thousand)
Table 02: Key Industry Acquisitions in Global Orthopedic Biomaterials Market, 2016–2018 (1/3)
Table 03: Key Industry Acquisitions in Global Orthopedic Biomaterials Market, 2016–2018 (2/3)
Table 04: Key Industry Acquisitions in Global Orthopedic Biomaterials Market, 2016–2018 (3/3)
Table 05: Medical Device Classification as per U.S. FDA
Table 06: Supplements for Pre-market Approval, by Type of Supplements, 1986–1997
Table 07: Global Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 08: Global Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 09: Global Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 10: Global Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 11: North America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 12: North America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 13: North America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 14: North America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 15: Europe Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Europe Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 17: Europe Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Europe Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 19: Asia Pacific Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Asia Pacific Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 21: Asia Pacific Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 22: Asia Pacific Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 23: Latin America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Latin America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 25: Latin America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 26: Latin America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 27: Middle East & Africa Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 28: Middle East & Africa Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 29: Middle East & Africa Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 30: Middle East & Africa Orthopedic Biomaterials Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global Orthopedic Biomaterials Market Snapshot
Figure 02: Global Orthopedic Biomaterials Market Value Share, by Material, 2018 and 2027
Figure 03: Global Orthopedic Biomaterials Market Attractiveness, by Material, 2018
Figure 04: Global Orthopedic Biomaterials Market Value(US$ Mn) and Y-o-Y Growth (%), by Glass-ceramic & Bioactive Glasses, 2017–2027
Figure 05: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Calcium Phosphate Cements, 2017–2027
Figure 06: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Polymers, 2017–2027
Figure 07: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Metals, 2017–2027
Figure 08: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Composites, 2017–2027
Figure 09: Global Orthopedic Biomaterials Market Value Share Analysis, by Application, 2018 and 2027
Figure 10: Global Orthopedic Biomaterials Market Attractiveness Analysis, by Application, 2018
Figure 11: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Joint Replacements, 2017–2027
Figure 12: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Spine Implants, 2017-2027
Figure 13: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Orthobiologics,2017–2027
Figure 14: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Viscosupplementation, 2017- 2027
Figure 15: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Bio-resorbable Tissue Fixation, 2017–2027
Figure 16: Global Orthopedic Biomaterials Market Value Share Analysis, by End-user, 2018 and 2027
Figure 17: Global Orthopedic Biomaterials Market Attractiveness Analysis, by End-user, 2018
Figure 18: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 19: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Orthopedic Clinics, 2017–2027
Figure 20: Global Orthopedic Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 21: Global Orthopedic Biomaterials Market Value Share Analysis, by Region, 2018 and 2027
Figure 22: Global Orthopedic Biomaterials Market Attractiveness Analysis, by Region, 2018
Figure 23: North America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, 2017–2027
Figure 24: North America Orthopedic Biomaterials Market Attractiveness Analysis, by Country, 2018
Figure 25: North America Orthopedic Biomaterials Market Value Share Analysis, by Country, 2018 and 2027
Figure 26: North America Orthopedic Biomaterials Market Value Share, by Material, 2018 and 2027
Figure 27: North America Orthopedic Biomaterials Market Attractiveness, by Material, 2018
Figure 28: North America Orthopedic Biomaterials Market Value Share Analysis, by Application, 2018 and 2027
Figure 29: North America Orthopedic Biomaterials Market Attractiveness Analysis, by Application, 2018
Figure 30: North America Orthopedic Biomaterials Market Value Share Analysis, by End-user, 2018 and 2027
Figure 31: North America Orthopedic Biomaterials Market Attractiveness Analysis, by End-user, 2018
Figure 32: Europe Orthopedic Biomaterials Market Value (US$ Mn) Forecast, 2017–2027
Figure 33: Europe Orthopedic Biomaterials Market Attractiveness, by Country/Sub-region, 2018
Figure 34: Europe Orthopedic Biomaterials Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 35: Europe Orthopedic Biomaterials Market Value Share, by Material, 2018 and 2027
Figure 36: Europe Orthopedic Biomaterials Market Attractiveness, by Material, 2018
Figure 37: Europe Orthopedic Biomaterials Market Value Share Analysis, by Application, 2018 and 2027
Figure 38: Europe Orthopedic Biomaterials Market Attractiveness Analysis, by Application, 2018
Figure 39: Europe Orthopedic Biomaterials Market Value Share Analysis, by End-user, 2018 and 2027
Figure 40: Europe Orthopedic Biomaterials Market Attractiveness Analysis, by End-user, 2018
Figure 41: Asia Pacific Orthopedic Biomaterials Market Value (US$ Mn) Forecast, 2017–2027
Figure 42: Asia Pacific Orthopedic Biomaterials Market Attractiveness Analysis, by Country/Sub-region, 2018
Figure 43: Asia Pacific Orthopedic Biomaterials Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 44: Asia Pacific Orthopedic Biomaterials Market Value Share, by Material, 2018 and 2027
Figure 45: Asia Pacific Orthopedic Biomaterials Market Attractiveness, by Material, 2018
Figure 46: Asia Pacific Orthopedic Biomaterials Market Value Share Analysis, by Application, 2018 and 2027
Figure 47: Asia Pacific Orthopedic Biomaterials Market Attractiveness Analysis, by Application, 2018
Figure 48: Asia Pacific Orthopedic Biomaterials Market Value Share Analysis, by End-user, 2018 and 2027
Figure 49: Asia Pacific Orthopedic Biomaterials Market Attractiveness Analysis, by End-user, 2018
Figure 50: Latin America Orthopedic Biomaterials Market Value (US$ Mn) Forecast, 2017–2027
Figure 51: Latin America Orthopedic Biomaterials Market Attractiveness, by Country/Sub-region, 2018
Figure 52: Latin America Orthopedic Biomaterials Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 53: Latin America Orthopedic Biomaterials Market Value Share, by Material, 2018 and 2027
Figure 54: Latin America Orthopedic Biomaterials Market Attractiveness, by Material, 2018
Figure 55: Latin America Orthopedic Biomaterials Market Value Share Analysis, by Application, 2018 and 2027
Figure 56: Latin America Orthopedic Biomaterials Market Attractiveness Analysis, by Application, 2018
Figure 57: Latin America Orthopedic Biomaterials Market Value Share Analysis, by End-user, 2018 and 2027
Figure 58: Latin America Orthopedic Biomaterials Market Attractiveness Analysis, by End-user, 2018
Figure 59: Middle East & Africa Orthopedic Biomaterials Market Value (US$ Mn) Forecast, 2017–2027
Figure 60: Middle East & Africa Orthopedic Biomaterials Market Attractiveness, by Country/Sub-region, 2018
Figure 61: Middle East & Africa Orthopedic Biomaterials Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 62: Middle East & Africa Orthopedic Biomaterials Market Value Share, by Material, 2018 and 2027
Figure 63: Middle East & Africa Orthopedic Biomaterials Market Attractiveness, by Material, 2018
Figure 64: Middle East & Africa Orthopedic Biomaterials Market Value Share Analysis, by Application, 2018 and 2027
Figure 65: Middle East & Africa Orthopedic Biomaterials Market Attractiveness Analysis, by Application, 2018
Figure 66: Middle East & Africa Orthopedic Biomaterials Market Value Share Analysis, by End-user, 2018 and 2027
Figure 67: Middle East & Africa Orthopedic Biomaterials Market Attractiveness Analysis, by End-user, 2018
Figure 68: Global Orthopedic Biomaterials Market Share, by Company, 2018
Figure 69: Zimmer Biomet Holdings, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018
Figure 70: Zimmer Biomet Holdings, Inc. Breakdown of Net Sales (%), by Region, 2018
Figure 71: Zimmer Biomet Holdings, Inc. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 72: Stryker Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 73: Stryker Breakdown of Net Sales (%), by Region, 2018
Figure 74: Stryker Breakdown of Net Sales (%), by Business Segment, 2018
Figure 75: Johnson & Johnson Orthopedics Franchise of Medical Devices Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 76: Johnson & Johnson Breakdown of Net Sales (%), by Region, 2018
Figure 77: Johnson & Johnson Breakdown of Net Sales (%), by Orthopedics Franchise of Medical Devices Business Segment, 2018
Figure 78: Smith & Nephew plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 79: Smith & Nephew plc Breakdown of Net Sales (%), by Region, 2018
Figure 80: Smith & Nephew plc Breakdown of Net Sales (%), by Orthopedics Business Segment, 2018
Figure 81: Medtronic Spine Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 82: Medtronic Restorative Therapies Group Breakdown of Net Sales (%), by Region, 2018
Figure 83: Medtronic Breakdown of Net Sales (%), by Orthopedics Business Segment, 2018
Figure 84: DJO Global, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 85: DJO Global, Inc. Breakdown of Net Sales (%), by Region, 2017
Figure 86: DJO Global, Inc. Breakdown of Net Sales (%), by Orthopedics Business Segment, 2017
Figure 87: NuVasive, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 88: NuVasive, Inc. Breakdown of Net Sales (%), by Region, 2018
Figure 89: NuVasive, Inc. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 90: Globus Medical, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 91: Globus Medical, Inc. Breakdown of Net Sales (%), by Region, 2017
Figure 92: Globus Medical, Inc. Breakdown of Net Sales (%), by Business Segment, 2017
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Orthopedic Biomaterials Market
